ATLANTA, April 29, 2014 /PRNewswire/ --
First Quarter Highlights:
•Grew HeRO® Graft revenues 26 percent year-over-year to $1.6 million
•Received FDA approval to begin PerClot® clinical trial
Help employers find you! Check out all the jobs and post your resume.